Effect of switching recombinant human growth hormone: Comparative analysis of phase 3 clinical data
نویسندگان
چکیده
منابع مشابه
Effect of switching recombinant human growth hormone: Comparative analysis of phase 3 clinical data
INTRODUCTION Recombinant human growth hormone (rhGH) is effective and safe when used to treat growth hormone deficiency (GHD) in children. However, it has been suggested that switching between different types of rhGH can have a detrimental effect on patients. METHODS The current analysis assessed the efficacy and safety of rhGH in children who received continuous Omnitrope® (Sandoz GmbH, Kund...
متن کاملthe effect analysis of proficiency on language - switching in iranian efl learners writing
abstract in a protocol analysis of second language writing from 20 adult english as a foreign language (efl) iranian students, this research observed how language-switching (l-s), i.e., first language use in l2 writing, was affected by l2 proficiency. switching interactively between first (l1) and second (l2) languages has been recognized as one of the salient characteristics of l2 writing....
15 صفحه اولPurification of Large Quantities of Biologically Active Recombinant Human Growth Hormone
Production and purification of human growth hormone using a simple method was studied in two recombinantEscherichia coli, D7-5 and C27-2 strains. The r-hGH was expressed in the form of inclusion body in a batchfermentation process and purified to 99% purity using a procedure based on acid precipitation of the hostderived proteins and other impurities. The effect of the pH and ...
متن کاملcomparative analysis of the use of hedges & emphatics in english and persian academic research articles of sociology & psychology
چکیده ندارد.
15 صفحه اولClinical evaluation of recombinant human growth hormone in Noonan syndrome.
The objective of this study was to investigate the effect of administration of recombinant human growth hormone (hGH) in patients with Noonan syndrome. hGH was administered (0.5 IU/kg/week) to 15 patients with Noonan syndrome over a 2 year period. Average patient age prior to therapy was 7.5 +/- 2.5 (mean +/- SD) yr, the height SD score was -2.8 +/- 0.7, and the pretreatment height velocity and...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Biologics in Therapy
سال: 2011
ISSN: 2190-9164
DOI: 10.1007/s13554-011-0004-8